Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular Carcinoma
Conditions: Liver Transplantation; Hepatocellular Carcinoma; Alpha-Fetoprotein; Protein Induced by Vitamin K Absence or Antagonist-II Sponsors: Zhejiang University; Shulan (Hangzhou) Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Hospitals | Liver | Liver Cancer | Liver Transplant | Research | Transplants | Urology & Nephrology | Vitamin K | Vitamins